Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.

Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.

BACKGROUND:To investigate the diagnostic and prognostic performances of 18F-FDG PET/CT measures of metabolic tumour burden in patients with neurofibromatosis type-1 (NF1), suspect of malignant transformation. METHODS:This retrospective study included 49 patients (15-60 years old, 30 women) with a di...

Full description

Bibliographic Details
Main Authors:	Axel Van Der Gucht, Ouidad Zehou, Soraya Djelbani-Ahmed, Laurence Valeyrie-Allanore, Nicolas Ortonne, Pierre Brugières, Pierre Wolkenstein, Alain Luciani, Alain Rahmouni, Emilie Sbidian, Emmanuel Itti
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4795780?pdf=render

Similar Items

Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1.
by: Patrick Combemale, et al.
Published: (2014-01-01)

Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study
by: Sbidian Emilie, et al.
Published: (2012-09-01)

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966
by: Christina Bergqvist, et al.
Published: (2020-02-01)

Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
by: Hadj-Rabia Smaïl, et al.
Published: (2011-05-01)

French referral center management of Stevens–Johnson syndrome/toxic epidermal necrolysis
by: Laurence Valeyrie-Allanore, et al.
Published: (2013-12-01)

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?
by: Bouvresse Sophie, et al.
Published: (2012-09-01)

Neurofibromatosis I and multiple sclerosis
by: Christina Bergqvist, et al.
Published: (2020-07-01)

Lymphoproliferative malignancies in patients with neurofibromatosis 1
by: Christina Bergqvist, et al.
Published: (2021-05-01)

Cerebral 18F-FDG PET in macrophagic myofasciitis: An individual SVM-based approach.
by: Paul Blanc-Durand, et al.
Published: (2017-01-01)

The effect of post-injection 18F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1
by: Eitan Lovat, et al.
Published: (2017-04-01)

Impact of the <sup>18</sup>F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients
by: Mathilde Vermersch, et al.
Published: (2021-09-01)

Prevalence and Description of Hidradenitis Suppurativa in Down Syndrome: A Cross-sectional Study of 783 Subjects
by: Florence Poizeau, et al.
Published: (2018-12-01)

Whole-Body Functional MRI and PET/MRI in Multiple Myeloma
by: Sébastien Mulé, et al.
Published: (2020-10-01)

Neuroendocrine tumour in a patient with neurofibromatosis type 1 and HIV
by: Juliane Hiesgen, et al.
Published: (2015-06-01)

Malignant peripheral nerve sheath tumours in a patient with Neurofibromatosis-1
by: Fatima Iqbal, et al.
Published: (2023-02-01)

Successful step-by-step treatment of multiple tumours in neurofibromatosis type 2
by: Andrii Sirko, et al.
Published: (2019-03-01)

Neurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesis
by: Spyk Sebastian, et al.
Published: (2011-10-01)

Neurofibromatosis type 1 presenting as bleeding jejunal gastrointestinal stromal tumour
by: Liang, Raymond Fueng-Hin, et al.
Published: (2024)

MIA is a potential biomarker for tumour load in neurofibromatosis type 1
by: Holtkamp Nikola, et al.
Published: (2011-07-01)

Anaesthetic Management of a Child with Neurofibromatosis Type 2 for Multiple Tumour Decompressions
by: Geetha Lakshiminarasimhaiah, et al.
Published: (2013-12-01)

Small bowel gastrointestinal stromal tumours and ampullary cancer in Type 1 neurofibromatosis
by: Fisher Cyril, et al.
Published: (2004-01-01)

Malignant peripheral nerve sheath tumour in a patient with a plexiform neurofibromatosis
by: Ravi Nekkanti, et al.
Published: (2015-01-01)

[18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
by: I. Gallais Sérézal, et al.
Published: (2021-01-01)

Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR
by: Wolkenstein Pierre, et al.
Published: (2004-07-01)

Neurofibromatosis Type 1 and pancreatic islet cell tumours: an association which should be recognized.
by: Rogers, A, et al.
Published: (2012)

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1Research in context
by: Charlotte Carton, et al.
Published: (2023-02-01)

Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.
by: Paul Blanc-Durand, et al.
Published: (2018-01-01)

The association of FDG-PET (SUVmax) and inflammatory marker in predicting tumour aggressiveness
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2018)

Malignant peripheral nerve sheath tumours and neurofibromatosis 1: A case series and recommendations for care
by: Henriette Burger, et al.
Published: (2018-08-01)

Neurofibromatosis
by: Koos E. Hovinga, et al.
Published: (2020-10-01)

Neurofibromatosis
by: Gerber PA, et al.
Published: (2009-03-01)

Meningiomas in patients with neurofibromatosis type 2 predominantly comprise ‘immunogenic subtype’ tumours characterised by macrophage infiltration
by: Yu Teranishi, et al.
Published: (2023-09-01)

Neurofibromatosis type 1‐associated malignant peripheral nerve sheath tumour carcinomatous pleurisy: an autopsy case
by: Marie Furukawa, et al.
Published: (2019-10-01)

Ocular neurofibromatosis
by: Rao Vasudev, et al.
Published: (1981-01-01)

Ocular neurofibromatosis
by: Singh Gurbax, et al.
Published: (1973-01-01)

Plexiform neurofibromatosis
by: Ganesh Avhad, et al.
Published: (2014-01-01)

Segmental Neurofibromatosis
by: Yesudian Devakar, et al.
Published: (1997-01-01)

Neurofibromatosis 2
by: Abhijit M Patil, et al.
Published: (2015-01-01)

Mosaic neurofibromatosis type 1 or segmental neurofibromatosis: what is in the name?
by: Kakar Shruti, et al.
Published: (2022-01-01)

Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study.
by: Seminog, O, et al.
Published: (2013)